2XQQ

Human dynein light chain (DYNLL2) in complex with an in vitro evolved peptide (Ac-SRGTQTE).

External Resource: Annotation

Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
B	PF01221	e2xqqB1	A: a+b two layers	X: DLC (From Topology)	H: DLC (From Topology)	T: DLC	F: PF01221	ECOD (1.6)
C	PF01221	e2xqqC1	A: a+b two layers	X: DLC (From Topology)	H: DLC (From Topology)	T: DLC	F: PF01221	ECOD (1.6)
D	PF01221	e2xqqD1	A: a+b two layers	X: DLC (From Topology)	H: DLC (From Topology)	T: DLC	F: PF01221	ECOD (1.6)
A	PF01221	e2xqqA1	A: a+b two layers	X: DLC (From Topology)	H: DLC (From Topology)	T: DLC	F: PF01221	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
B	3.30.740.10	Alpha Beta	2-Layer Sandwich	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	CATH (4.3.0)
C	3.30.740.10	Alpha Beta	2-Layer Sandwich	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	CATH (4.3.0)
D	3.30.740.10	Alpha Beta	2-Layer Sandwich	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	CATH (4.3.0)
A	3.30.740.10	Alpha Beta	2-Layer Sandwich	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	Protein Inhibitor Of Neuronal Nitric Oxide Synthase	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D	PF01221	Dynein light chain type 1 (Dynein_light)	Dynein light chain type 1	-	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	DYNEIN LIGHT CHAIN 2, CYTOPLASMIC	protein binding binding dynein intermediate chain binding	microtubule-based process cellular process	membrane-bounded organelle cell projection organelle cilium cellular anatomical entity plasma membrane bounded cell projection membrane intracellular organelle intracellular anatomical structure cytoskeleton intracellular non-membrane-bounded organelle non-membrane-bounded organelle centrosome microtubule organizing center membrane-bounded organelle cell projection organelle cilium cellular anatomical entity plasma membrane bounded cell projection membrane intracellular organelle intracellular anatomical structure cytoskeleton intracellular non-membrane-bounded organelle non-membrane-bounded organelle centrosome microtubule organizing center microtubule cytoskeleton cytoplasm cytosol ciliary tip cell periphery plasma membrane postsynapse synapse cell junction protein-containing complex cytoplasmic dynein complex catalytic complex dynein complex microtubule associated complex non-motile cilium 9+0 non-motile cilium glutamatergic synapse polymeric cytoskeletal fiber supramolecular fiber microtubule supramolecular polymer supramolecular complex actin cytoskeleton myosin complex myosin V complex unconventional myosin complex nucleus intracellular membrane-bounded organelle
E, F, G, H	SAC-ARG-GLY-THR-GLN-THR-GLU	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR037177	Dynein light chain superfamily	Homologous Superfamily
A, B, C, D	IPR001372	Dynein light chain, type 1/2	Family
A, B, C, D	IPR019763	Dynein light chain, type 1/2, conserved site	Conserved Site

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D	Pharos: Q96FJ2	adrenal cortex carcinoma malignant ependymoma tuberculosis atypical teratoid rhabdoid tumor osteosarcoma hepatocellular carcinoma pancreatic ductal adenocarcinoma

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.